Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco.

The Global Healthy Living Foundation (GHLF) and Guardant Health today announced a new partnership aimed at improving public understanding of colorectal cancer and encouraging timely screening through ...

We recently compiled a list of the 7 Most Promising Gene Editing Stocks According to Analysts. Guardant Health, Inc. is one ...

Guardant Health ( GH) leads the pack with an impressive YTD performance of +226.48%, earning a Strong Buy Quant Rating.

In the last three months, 7 analysts have published ratings on Guardant Health (NASDAQ:GH), offering a diverse range of perspectives from bullish to bearish. The following table provides a quick ...

(Reuters) - Guardant Health said its blood test to detect cancer that starts in the colon or rectum got an approval from the U.S. Food and Drug Administration, with the test moving closer toward ...

PALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (GH), a leading precision oncology company, today announced its Shield blood test for colorectal cancer (CRC) screening has been named a ...

Company officials say the new partnership will make it easier for health systems, community providers and retail clinics to provide direct ordering, access and delivery of Guardant Health blood tests.

I was a little late to the party in buying Guardant Health (GH-3.35%). After watching the stock soar during the latter part of 2018 and the first half of 2019, I finally jumped in to scoop up shares ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a partnership with Epic, the nation’s most widely used comprehensive ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, ...

Craig-Hallum used to like Exact Sciences stock -- but now it likes Guardant Health even more. Five years from now, the investment banker thinks Guardant's annual revenue could be three times what it ...